Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis-Reference-Cited by-同舟云学术

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis

Published:2009-02 Issue:2 Volume:60 Page:335-344
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Cohen Stanley B.,Cheng Tien-Tsai,Chindalore Vishala,Damjanov Nemanja,Burgos-Vargas Ruben,DeLora Patricia,Zimany Kathleen,Travers Helen,Caulfield John P.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference28 articles.

1. Pathway to the clinic: inhibition of p38 MAP kinase. A review of ten chemotypes selected for development;Goldstein;Curr Top Med Chem,2005

2. Novel pathways that regulate tumor necrosis factor-α production in rheumatoid arthritis;Gracie;Curr Opin Rheumatol,2002

3. Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases;Salituro;Curr Med Chem,1999

4. p38 MAPK signalling cascades in inflammatory disease;Herlaar;Mol Med Today,1999

5. Induction of cyclooxygenase-2 by the activated MEKK1→ SEK1/MKK4→p38 mitogen-activated protein kinase pathway;Guan;J Biol Chem,1998

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remodeling tumor‐associated macrophage for anti‐cancer effects by rational design of irreversible inhibition of mitogen‐activated protein kinase‐activated protein kinase 2;MedComm;2024-07

2. Increased mRNA expression of ADAMTS1 and ADAMTS4 in peripheral blood mononuclear cells of psoriasis patients developed psoriatic arthritis;Periodicum Biologorum;2024-06-19

3. Helicobacter pylori disrupts gastric mucosal homeostasis by stimulating macrophages to secrete CCL3;Cell Communication and Signaling;2024-05-10

4. NJK14047 inhibition of p38 MAPK ameliorates inflammatory immune diseases by suppressing T cell differentiation;International Immunopharmacology;2024-03

5. Developmental drugs for sarcoidosis;Journal of Autoimmunity;2024-03